Virtual reality as an adjunct to anesthesia in the operating room.
Adult
Anesthesia, Conduction
/ methods
Anesthetics, Intravenous
/ administration & dosage
Anxiety
/ etiology
Humans
Operating Rooms
/ methods
Orthopedic Procedures
/ methods
Outcome Assessment, Health Care
Pain, Procedural
/ prevention & control
Propofol
/ administration & dosage
Randomized Controlled Trials as Topic
Relaxation Therapy
/ methods
Research Design
Virtual Reality
Monitored anesthesia care
Propofol
Regional
Upper extremity surgery
Virtual reality
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
27 Dec 2019
27 Dec 2019
Historique:
received:
04
09
2019
accepted:
20
11
2019
entrez:
29
12
2019
pubmed:
29
12
2019
medline:
20
9
2020
Statut:
epublish
Résumé
Advancements in virtual reality (VR) technology have resulted in its expansion into health care. Preliminary studies have found VR to be effective as an adjunct to anesthesia to reduce pain and anxiety for patients during upper gastrointestinal endoscopies, dental procedures and joint arthroplasties. Current standard care practice for upper extremity surgery includes a combination of regional anesthesia and intraoperative propofol sedation. Commonly, patients receive deep propofol sedation during these cases, leading to potentially avoidable risks of over-sedation, hypotension, upper airway obstruction, and apnea. The objective of this study is to evaluate the effectiveness of VR technology to promote relaxation for patients undergoing upper extremity surgery, thereby reducing intraoperative anesthetic requirements and improving the perioperative patient experience. In this single-center, randomized controlled trial, 40 adult patients undergoing upper extremity orthopedic surgery will be randomly allocated to either intraoperative VR immersion or usual care. VR immersion is designed to provide patients with a relaxing virtual environment to alleviate intraoperative anxiety. All patients receive a peripheral nerve block prior to surgery. Patients in the intervention group will select videos or immersive environments which will be played in the VR headset during surgery. An anesthesia provider will perform their usual clinical responsibilities intraoperatively and can administer anesthetic medications if and when clinically necessary. Patients in the control arm will undergo perioperative anesthesia according to standard care practice. The primary outcome is the difference in intraoperative propofol dose between the groups. Secondary outcomes include postoperative analgesia requirements and pain scores, length of stay in the postanesthesia care unit, overall patient satisfaction and postoperative functional outcomes. It is unknown whether the use of VR during upper extremity surgery can reduce intraoperative anesthetic requirements, reduce perioperative complications, or improve the postoperative patient experience. A positive result from this clinical trial would add to the growing body of evidence that demonstrates the effectiveness of VR as an adjunct to anesthesia in reducing intraoperative pain and anxiety for multiple types of procedure. This could lead to a change in practice, with the introduction of a nonpharmacologic intervention potentially reducing the burden of over-sedation while still providing a satisfactory perioperative experience. ClinicalTrials.gov, NCT03614325. Registered on 9 July 2018.
Sections du résumé
BACKGROUND
BACKGROUND
Advancements in virtual reality (VR) technology have resulted in its expansion into health care. Preliminary studies have found VR to be effective as an adjunct to anesthesia to reduce pain and anxiety for patients during upper gastrointestinal endoscopies, dental procedures and joint arthroplasties. Current standard care practice for upper extremity surgery includes a combination of regional anesthesia and intraoperative propofol sedation. Commonly, patients receive deep propofol sedation during these cases, leading to potentially avoidable risks of over-sedation, hypotension, upper airway obstruction, and apnea. The objective of this study is to evaluate the effectiveness of VR technology to promote relaxation for patients undergoing upper extremity surgery, thereby reducing intraoperative anesthetic requirements and improving the perioperative patient experience.
METHODS
METHODS
In this single-center, randomized controlled trial, 40 adult patients undergoing upper extremity orthopedic surgery will be randomly allocated to either intraoperative VR immersion or usual care. VR immersion is designed to provide patients with a relaxing virtual environment to alleviate intraoperative anxiety. All patients receive a peripheral nerve block prior to surgery. Patients in the intervention group will select videos or immersive environments which will be played in the VR headset during surgery. An anesthesia provider will perform their usual clinical responsibilities intraoperatively and can administer anesthetic medications if and when clinically necessary. Patients in the control arm will undergo perioperative anesthesia according to standard care practice. The primary outcome is the difference in intraoperative propofol dose between the groups. Secondary outcomes include postoperative analgesia requirements and pain scores, length of stay in the postanesthesia care unit, overall patient satisfaction and postoperative functional outcomes.
DISCUSSION
CONCLUSIONS
It is unknown whether the use of VR during upper extremity surgery can reduce intraoperative anesthetic requirements, reduce perioperative complications, or improve the postoperative patient experience. A positive result from this clinical trial would add to the growing body of evidence that demonstrates the effectiveness of VR as an adjunct to anesthesia in reducing intraoperative pain and anxiety for multiple types of procedure. This could lead to a change in practice, with the introduction of a nonpharmacologic intervention potentially reducing the burden of over-sedation while still providing a satisfactory perioperative experience.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov, NCT03614325. Registered on 9 July 2018.
Identifiants
pubmed: 31882015
doi: 10.1186/s13063-019-3922-2
pii: 10.1186/s13063-019-3922-2
pmc: PMC6935058
doi:
Substances chimiques
Anesthetics, Intravenous
0
Propofol
YI7VU623SF
Banques de données
ClinicalTrials.gov
['NCT03614325']
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
782Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Am J Ind Med. 1996 Jun;29(6):602-8
pubmed: 8773720
Anesthesiology. 2006 Feb;104(2):228-34
pubmed: 16436839
Anesthesiology. 2016 Oct;125(4):700-15
pubmed: 27483127
Clin J Pain. 2009 Nov-Dec;25(9):815-26
pubmed: 19851164
Anesth Analg. 2017 Oct;125(4):1200-1202
pubmed: 28598921
Mayo Clin Proc. 2010 Jan;85(1):18-26
pubmed: 20042557
JMIR Ment Health. 2017 Mar 29;4(1):e9
pubmed: 28356241
J Am Dent Assoc. 2009 Dec;140(12):1508-16
pubmed: 19955069
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Br J Anaesth. 2016 Jun;116(6):784-9
pubmed: 27199311
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Anesth Analg. 2019 Jun;128(6):e93-e96
pubmed: 31094789
Games Health J. 2017 Oct;6(5):263-270
pubmed: 28759254